SCHEMBL6662063

SCHEMBL6662063

c1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.62
PI4KA P42356 1/20 0.62
PI4K2B Q8TCG2 1/20 0.62
PI4K2A Q9BTU6 1/20 0.62
PI4KB Q9UBF8 1/20 0.62
DAPK1 P53355 1/20 0.58
SLC29A1 Q99808 2/20 0.57
CYP1A2 P05177 2/20 0.53
HTT P42858 1/20 0.53
HRH4 Q9H3N8 1/20 0.53
HPGD P15428 1/20 0.51
PDE4A P27815 1/20 0.51
PDE4B Q07343 1/20 0.51
PDE4C Q08493 1/20 0.51
PDE4D Q08499 1/20 0.51
ALDH1A1 P00352 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HIF1A Q16665 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31060284 1.00 ADORA2A (0.62) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL31061437 0.91 SLC29A1 (0.56) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL31060261 0.91 ADORA2A (0.55) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL6659707 0.91 ADORA2A (0.55) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL6666118 0.91 SLC29A1 (0.56) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL6660729 0.84 SLC29A1 (0.59) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL2980291 0.78 ADORA2A (0.70) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL30984022 0.78 ADORA2A (0.70) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL6661513 0.77 SLC29A1 (0.49) ADORA2ASLC29A1CYP1A2HPGDALDH1A1
SCHEMBL2979897 0.77 ADORA2A (0.68) ADORA2API4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444982-A1 The use of purine derivatives as selective kinase inhibitors MERCKLE GMBH (DE) 2004-08-11 EP disclosed